arrow
M

Michelle A. Lifton

Beth Israel Deaconess Medical Center
H指数:46
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines

挖掘CD4抗原谱以开发下一代结核病疫苗

Cell
IF42.5
2025-09-150
OAAI
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
2022-11-2590
OAAI
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
2022-11-234
OAAI
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques
2022-03-3013
OAAI
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
2021-09-2322
OAAI
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center
2021-01-255
OAAI
Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques

猿猴-人类免疫缺陷病毒/猿猴免疫缺陷病毒感染的婴儿恒河猴中粘膜3组固有淋巴样和自然杀伤细胞的功能扰动

2020-02-149
OAAI
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Science
IF45.8
2020-01-010
OAAI
Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy
2019-11-2014
OAAI
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
2016-11-0131
OAAI
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
2016-02-1112
OAAI
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
2015-06-1540
OAAI